EVGN EVOGENE LTD. · XNAS
0.38 +33.7% as of Nov 10, 13:55 ET
fans
What's happening Live detector signal Generated 00:43 ET
Share structure
Free float
9.2M
2026-08-18
Shares out
13.6M
latest detail
Market cap
$5.1M
at ref price
Short interest
0.8%
2026-10-30
Float rotation
0.16×
latest snapshot
20d dollar vol
$214.5K
baseline
Supply intelligence
Gap quality
squeeze-prone · 84
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
low float
detector reason
Supply factor
meaningful float rotation
detector reason
Supply factor
nano-cap supply profile
detector reason

This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.

Filings and news
2026-11-10 13:55 ETSignalEVOGENE LTD is up 33.7%, at 0.38, on $549.1K traded, 3.2× 20-day volume, 0.16× float rotation. Score 92. Primary driver: 15.6% float rotation. Supply intelligence: squeeze-prone · 84.
2026-09-29EFFECTPotential financing or dilution-related filing. SEC
2026-07-17424B5Potential financing or dilution-related filing. SEC
2026-06-11424B5Potential financing or dilution-related filing. SEC
2026-05-20424B3Potential financing or dilution-related filing. SEC
2026-04-15EFFECTPotential financing or dilution-related filing. SEC
2026-04-03EFFECTPotential financing or dilution-related filing. SEC
2024-07-19 13:26 ETGeneralPlant Genotyping Equipment Market Size to Hit 1662.43 - GlobeNewswire News
2024-07-18 17:02 ETGeneralGlobal Agricultural Biotechnology Market Size To Worth USD 268.32 Billion By 2033 | CAGR of 8.27% - GlobeNewswire News
2024-03-07 09:20 ETEarnings GuidanceEvogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates News
2024-02-28 17:35 ETEarnings GuidanceMirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates News
Latest detector signalscore 92
score 92